{"id":12038,"date":"2021-02-08T15:58:21","date_gmt":"2021-02-08T15:58:21","guid":{"rendered":"https:\/\/clone.arsacs.com\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/"},"modified":"2021-02-08T16:28:58","modified_gmt":"2021-02-08T16:28:58","slug":"la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/","title":{"rendered":"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares"},"content":{"rendered":"<p>La Fondation est heureuse d\u2019annoncer qu\u2019elle repr\u00e9sentera les patients de l\u2019ARSACS dans le cadre du projet de recherche <em>\u201cDesigning a toolbox of paradigmatic treatments for a targeted molecular medicine approach to autosomal-recessive ataxias\u201d <\/em>. Le projet a re\u00e7u des fonds du programme de recherche et d\u2019innovation Horizon 2020 de l\u2019Union europ\u00e9enne sous EJPR (European Joint Programme Rare Diseases)  COFUND-EJP N\u00b0 825575. L\u2019objectif sp\u00e9cifique est la recherche pr\u00e9clinique pour d\u00e9velopper des th\u00e9rapies efficaces pour les maladies rares. On vise \u00e0 concevoir et \u00e0 tester de nouvelles strat\u00e9gies de traitement compl\u00e9mentaires, y compris des mol\u00e9cules r\u00e9utilis\u00e9es et nouvellement identifi\u00e9es, ainsi que des th\u00e9rapies g\u00e9niques dans deux multisyst\u00e8mes ARCAS exemplaires: l\u2019ataxie spastique r\u00e9cessive autosomique de Charlevoix-Saguenay (ARSACS) et COQ8A-ataxie (ARCA2). Il s\u2019agit d\u2019un projet de 3 ans.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Fondation est heureuse d\u2019annoncer qu\u2019elle repr\u00e9sentera les patients de l\u2019ARSACS dans le cadre du projet de recherche \u201cDesigning a toolbox of paradigmatic treatments for a targeted molecular medicine approach to autosomal-recessive ataxias\u201d . Le projet a re\u00e7u des fonds du programme de recherche et d\u2019innovation Horizon 2020 de l\u2019Union europ\u00e9enne sous EJPR (European Joint [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":11559,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[28],"tags":[],"class_list":["post-12038","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dernieres-nouvelles"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares - ARSACS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares - ARSACS\" \/>\n<meta property=\"og:description\" content=\"La Fondation est heureuse d\u2019annoncer qu\u2019elle repr\u00e9sentera les patients de l\u2019ARSACS dans le cadre du projet de recherche \u201cDesigning a toolbox of paradigmatic treatments for a targeted molecular medicine approach to autosomal-recessive ataxias\u201d . Le projet a re\u00e7u des fonds du programme de recherche et d\u2019innovation Horizon 2020 de l\u2019Union europ\u00e9enne sous EJPR (European Joint [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/\" \/>\n<meta property=\"og:site_name\" content=\"ARSACS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100044457429916\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-08T15:58:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-02-08T16:28:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/image187_w1000.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"812\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ARSACS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ARSACS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/\"},\"author\":{\"name\":\"ARSACS\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#\\\/schema\\\/person\\\/93b66d6b897bfa131622d04b767b15f1\"},\"headline\":\"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares\",\"datePublished\":\"2021-02-08T15:58:21+00:00\",\"dateModified\":\"2021-02-08T16:28:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/\"},\"wordCount\":163,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/image187_w1000.png\",\"articleSection\":[\"Derni\u00e8res Nouvelles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/\",\"url\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/\",\"name\":\"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares - ARSACS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/image187_w1000.png\",\"datePublished\":\"2021-02-08T15:58:21+00:00\",\"dateModified\":\"2021-02-08T16:28:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/#primaryimage\",\"url\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/image187_w1000.png\",\"contentUrl\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/image187_w1000.png\",\"width\":1000,\"height\":812},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/fr\\\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/arsacs.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#website\",\"url\":\"https:\\\/\\\/arsacs.com\\\/\",\"name\":\"Fondation de l'Ataxie Charlevoix-Saguenay\",\"description\":\"Research That Heals\",\"publisher\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/arsacs.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#organization\",\"name\":\"ARSACS\",\"url\":\"https:\\\/\\\/arsacs.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo_ARSACS_fr_flat.png\",\"contentUrl\":\"https:\\\/\\\/arsacs.com\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo_ARSACS_fr_flat.png\",\"width\":291,\"height\":84,\"caption\":\"ARSACS\"},\"image\":{\"@id\":\"https:\\\/\\\/arsacs.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=100044457429916\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/arsacs.com\\\/#\\\/schema\\\/person\\\/93b66d6b897bfa131622d04b767b15f1\",\"name\":\"ARSACS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g\",\"caption\":\"ARSACS\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares - ARSACS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/","og_locale":"fr_FR","og_type":"article","og_title":"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares - ARSACS","og_description":"La Fondation est heureuse d\u2019annoncer qu\u2019elle repr\u00e9sentera les patients de l\u2019ARSACS dans le cadre du projet de recherche \u201cDesigning a toolbox of paradigmatic treatments for a targeted molecular medicine approach to autosomal-recessive ataxias\u201d . Le projet a re\u00e7u des fonds du programme de recherche et d\u2019innovation Horizon 2020 de l\u2019Union europ\u00e9enne sous EJPR (European Joint [&hellip;]","og_url":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/","og_site_name":"ARSACS","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100044457429916","article_published_time":"2021-02-08T15:58:21+00:00","article_modified_time":"2021-02-08T16:28:58+00:00","og_image":[{"width":1000,"height":812,"url":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/image187_w1000.png","type":"image\/jpeg"}],"author":"ARSACS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ARSACS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/#article","isPartOf":{"@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/"},"author":{"name":"ARSACS","@id":"https:\/\/arsacs.com\/#\/schema\/person\/93b66d6b897bfa131622d04b767b15f1"},"headline":"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares","datePublished":"2021-02-08T15:58:21+00:00","dateModified":"2021-02-08T16:28:58+00:00","mainEntityOfPage":{"@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/"},"wordCount":163,"commentCount":0,"publisher":{"@id":"https:\/\/arsacs.com\/#organization"},"image":{"@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/#primaryimage"},"thumbnailUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/image187_w1000.png","articleSection":["Derni\u00e8res Nouvelles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/","url":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/","name":"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares - ARSACS","isPartOf":{"@id":"https:\/\/arsacs.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/#primaryimage"},"image":{"@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/#primaryimage"},"thumbnailUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/image187_w1000.png","datePublished":"2021-02-08T15:58:21+00:00","dateModified":"2021-02-08T16:28:58+00:00","breadcrumb":{"@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/#primaryimage","url":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/image187_w1000.png","contentUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/image187_w1000.png","width":1000,"height":812},{"@type":"BreadcrumbList","@id":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/arsacs.com\/"},{"@type":"ListItem","position":2,"name":"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares"}]},{"@type":"WebSite","@id":"https:\/\/arsacs.com\/#website","url":"https:\/\/arsacs.com\/","name":"Fondation de l'Ataxie Charlevoix-Saguenay","description":"Research That Heals","publisher":{"@id":"https:\/\/arsacs.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/arsacs.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/arsacs.com\/#organization","name":"ARSACS","url":"https:\/\/arsacs.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/arsacs.com\/#\/schema\/logo\/image\/","url":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/06\/logo_ARSACS_fr_flat.png","contentUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/06\/logo_ARSACS_fr_flat.png","width":291,"height":84,"caption":"ARSACS"},"image":{"@id":"https:\/\/arsacs.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100044457429916"]},{"@type":"Person","@id":"https:\/\/arsacs.com\/#\/schema\/person\/93b66d6b897bfa131622d04b767b15f1","name":"ARSACS","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g","caption":"ARSACS"}}]}},"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/12038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=12038"}],"version-history":[{"count":0,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/12038\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media\/11559"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=12038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=12038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=12038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}